These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 29202460)

  • 1. Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity.
    Chang SY; Weber EJ; Sidorenko VS; Chapron A; Yeung CK; Gao C; Mao Q; Shen D; Wang J; Rosenquist TA; Dickman KG; Neumann T; Grollman AP; Kelly EJ; Himmelfarb J; Eaton DL
    JCI Insight; 2017 Nov; 2(22):. PubMed ID: 29202460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase.
    Stiborová M; Frei E; Sopko B; Sopková K; Marková V; Lanková M; Kumstýrová T; Wiessler M; Schmeiser HH
    Carcinogenesis; 2003 Oct; 24(10):1695-703. PubMed ID: 12869422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of dicoumarol on the bioactivation of the carcinogen aristolochic acid I in rats.
    Stiborová M; Levová K; Bárta F; Šulc M; Frei E; Arlt VM; Schmeiser HH
    Mutagenesis; 2014 May; 29(3):189-200. PubMed ID: 24598128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of ochratoxin A on DNA adduct formation by the carcinogen aristolochic acid in rats.
    Stiborová M; Bárta F; Levová K; Hodek P; Frei E; Arlt VM; Schmeiser HH
    Arch Toxicol; 2015 Nov; 89(11):2141-58. PubMed ID: 25209566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aristolochic acid I metabolism in the isolated perfused rat kidney.
    Priestap HA; Torres MC; Rieger RA; Dickman KG; Freshwater T; Taft DR; Barbieri MA; Iden CR
    Chem Res Toxicol; 2012 Jan; 25(1):130-9. PubMed ID: 22118289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Aristolochic acid I derived DNA adduct levels in human renal toxicity models.
    Bastek H; Zubel T; Stemmer K; Mangerich A; Beneke S; Dietrich DR
    Toxicology; 2019 May; 420():29-38. PubMed ID: 30940547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of renal NQO1 activity by dicoumarol suppresses nitroreduction of aristolochic acid I and attenuates its nephrotoxicity.
    Chen M; Gong L; Qi X; Xing G; Luan Y; Wu Y; Xiao Y; Yao J; Li Y; Xue X; Pan G; Ren J
    Toxicol Sci; 2011 Aug; 122(2):288-96. PubMed ID: 21613233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Frei E; Sopko B; Wiessler M; Schmeiser HH
    Carcinogenesis; 2002 Apr; 23(4):617-25. PubMed ID: 11960915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactivation of the human carcinogen aristolochic acid.
    Sidorenko VS; Attaluri S; Zaitseva I; Iden CR; Dickman KG; Johnson F; Grollman AP
    Carcinogenesis; 2014 Aug; 35(8):1814-22. PubMed ID: 24743514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of activation of aristolochic acid I and II with NADPH:quinone oxidoreductase, sulphotransferases and N-acetyltranferases.
    Martinek V; Kubickova B; Arlt VM; Frei E; Schmeiser HH; Hudecek J; Stiborova M
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():57-70. PubMed ID: 22167209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver.
    Mei N; Arlt VM; Phillips DH; Heflich RH; Chen T
    Mutat Res; 2006 Dec; 602(1-2):83-91. PubMed ID: 17010389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Hájek M; Frei E; Schmeiser HH
    Gen Physiol Biophys; 2001 Dec; 20(4):375-92. PubMed ID: 11989648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfotransferase-1A1-dependent bioactivation of aristolochic acid I and N-hydroxyaristolactam I in human cells.
    Hashimoto K; Zaitseva IN; Bonala R; Attaluri S; Ozga K; Iden CR; Johnson F; Moriya M; Grollman AP; Sidorenko VS
    Carcinogenesis; 2016 Jul; 37(7):647-655. PubMed ID: 27207664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Renal Aquaporins in Aristolochic Acid I and Aristolactam I-Induced Nephrotoxicity.
    Li J; Zhang L; Jiang Z; He X; Zhang L; Xu M
    Nephron; 2016; 133(3):213-21. PubMed ID: 27352112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 1A2 detoxicates aristolochic acid in the mouse.
    Rosenquist TA; Einolf HJ; Dickman KG; Wang L; Smith A; Grollman AP
    Drug Metab Dispos; 2010 May; 38(5):761-8. PubMed ID: 20164109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative determination of aristolochic acid-derived DNA adducts in rats using 32P-postlabeling/polyacrylamide gel electrophoresis analysis.
    Dong H; Suzuki N; Torres MC; Bonala RR; Johnson F; Grollman AP; Shibutani S
    Drug Metab Dispos; 2006 Jul; 34(7):1122-7. PubMed ID: 16611860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of DNA and RNA Adduct Formation: Significantly Higher Levels of RNA than DNA Modifications in the Internal Organs of Aristolochic Acid-Dosed Rats.
    Leung EM; Chan W
    Chem Res Toxicol; 2015 Feb; 28(2):248-55. PubMed ID: 25555167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skullcapflavone II, a novel NQO1 inhibitor, alleviates aristolochic acid I-induced liver and kidney injury in mice.
    Dong YP; Chen SZ; He HS; Sun ZR; Jiang LX; Gu YQ; Zhang Y; Feng F; Chen C; Fan ZC; Chen XF; Wen W; Wang HY
    Acta Pharmacol Sin; 2023 Jul; 44(7):1429-1441. PubMed ID: 36697978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiles distinguish the carcinogenic effects of aristolochic acid in target (kidney) and non-target (liver) tissues in rats.
    Chen T; Guo L; Zhang L; Shi L; Fang H; Sun Y; Fuscoe JC; Mei N
    BMC Bioinformatics; 2006 Sep; 7 Suppl 2(Suppl 2):S20. PubMed ID: 17118142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary Time- or Dose-Dependent Metabolic Biomarkers of Aristolochic Acid-Induced Nephrotoxicity in Rats.
    Hu X; Shen J; Pu X; Zheng N; Deng Z; Zhang Z; Li H
    Toxicol Sci; 2017 Mar; 156(1):123-132. PubMed ID: 28115647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.